NCT07237139

Brief Summary

Current evidence suggests that noninvasive positive pressure ventilation (NIPPV) is more effective than continuous positive airway pressure (CPAP) in preventing respiratory failure in preterm infants with respiratory distress syndrome (RDS), both as initial and post-extubation support. NIPPV may be delivered in synchronized (sNIPPV) or non-synchronized (nsNIPPV) modes, with sNIPPV offering clear benefits by coordinating support with the infant's own breathing. Recent studies indicate sNIPPV is superior to nsNIPPV in preventing respiratory failure, though the intrapulmonary mechanisms behind this advantage remain unclear. To address this, the present study uses Electrical Impedance Tomography (EIT) to evaluate how lung volume changes during different types of breaths and ventilator inflations - spontaneous breaths, synchronized inflations, non-synchronized inflations, and backup inflations - in preterm infants receiving sNIPPV.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for all trials

Timeline
9mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Nov 2025Jan 2027

First Submitted

Initial submission to the registry

November 14, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

November 17, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 19, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2027

Last Updated

December 9, 2025

Status Verified

December 1, 2025

Enrollment Period

1.1 years

First QC Date

November 14, 2025

Last Update Submit

December 8, 2025

Conditions

Keywords

Synchronized noninvasive positive pressure ventilation (SNIPPV)Lung volumeElectrical Impedance Tomography (EIT)infant, preterm

Outcome Measures

Primary Outcomes (1)

  • Tidal volume (VT)

    Difference in relative VT (rel. ΔZ) between spontaneous breaths and synchronized inflations.

    At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

Secondary Outcomes (12)

  • Global lung impedance

    At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  • Regional tidal volume distribution

    At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  • Center of ventilation

    At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  • Silent spaces

    At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  • Global inhomogeneity index

    At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  • +7 more secondary outcomes

Study Arms (1)

Preterm infants with a gestational age < 30 0/7 weeks at birth

Infants on sNIPPV respiratory support and below 4 weeks chronological age

Device: Electrical Impedance Tomography (EIT)

Interventions

Electrical Impedance Tomography and clinical data will be recorded continuously. Corresponding data will be extracted and analyzed at five pre-defined timepoints.

Preterm infants with a gestational age < 30 0/7 weeks at birth

Eligibility Criteria

AgeUp to 4 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

This study will take place at the Department of Neonatology of the University Hospital Zurich. Preterm infants on a synchronized mode of non-invasive positive pressure ventilation will be screened for eligibility and parents will be approached by the treating physician or a clinician-researcher who is authorized to access the patient's clinical data.

You may qualify if:

  • Written informed consent by one or both parents or legal guardians
  • Gestational age at birth \< 30 0/7 weeks
  • Infants on sNIPPV respiratory support
  • Below 4 weeks chronological age

You may not qualify if:

  • Severe congenital malformation adversely affecting lung aeration or perfusion (e.g., congenital heart defects)
  • Too ill/unstable in the opinion of the treating physician.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Zurich

Zurich, Canton of Zurich, 8091, Switzerland

RECRUITING

MeSH Terms

Conditions

Premature BirthPulmonary Atelectasis

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesLung DiseasesRespiratory Tract Diseases

Study Officials

  • Vincenzo Cannizzaro, MD

    Newborn Research, Department of Neonatology, University Hospital and University of Zurich, Zurich, Switzerland

    STUDY CHAIR

Central Study Contacts

Christoph M Rüegger, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2025

First Posted

November 19, 2025

Study Start

November 17, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

January 30, 2027

Last Updated

December 9, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations